爱施健助推Tirzepatide(Mounjaro®)南非上市,提升患者可及性

约翰内斯堡 – 南非证券交易所(JSE)上市公司Aspen Pharmacare Holdings Limited(爱施健制药公司),作为一家全球领先的专业制药企业,近日宣布礼来公司(Eli Lilly,以下简称“礼来”)研发的创新药物 Tirzepatide(全球品牌名为 Mounjaro®)正式在南非上市。

Closed Period

Aspen is in a closed period from 1 January until the publication of our interim results on the JSE SENS platform scheduled to be released on 1 March 2023.

The live presentation will take place in Cape Town at 08h30 on 2 March 2023.